title: Study of oxidative DNA damage in TK6 human lymphoblastoid cells by use of the thymidine kinase gene-mutation assay and the in vitro modified comet assay: determination of No-Observed-Genotoxic-Effect-Levels.
abstract: Nowadays, there is clear progress in using the threshold concept in genetic toxicology, but its demonstration and acceptance in risk assessment is still under debate. Although it has been accepted for some non-DNA-reactive agents for which mechanisms of action were demonstrated, there is a growing weight of evidence to also support the existence of thresholded dose-responses for DNA-reactive agents. In this context, we have recently shown in human TK6 lymphoblastoid cells, that DNA-oxidizing agents [potassium bromate, bleomycin and hydrogen peroxide (via glucose oxidase)] produced non-linear dose-responses in the in vitro micronucleus test, thus allowing the determination of No-Observed-Genotoxic-Effect-Levels (NOGELs). Therefore, the aim of the present study was to focus on the analysis of thresholded dose-response curves in order to further investigate the existence of NOGELs for these same directly DNA-damaging agents, by use of other genotoxicity endpoints. Mutation frequency was determined after a 1-h treatment in the thymidine kinase (TK) gene-mutation assay. Primary DNA damage, especially oxidative DNA damage, was also assessed after 1h of treatment, followed - or not - by a 23-h recovery period, with the modified version of the comet assay (i.e. with the glycosylases Fpg and hOgg1). Overall, our analysis demonstrates that there is convincing evidence to support the existence of thresholded dose-responses for DNA-oxidizing agents. The determination of NOGELs depends on the genotoxic endpoint studied and consequently requires different genotoxicity assays performed concurrently. NOGELs could only be defined for the induction of chromosomal aberrations and gene mutations, i.e. for an effect-endpoint but not for primary DNA damage, i.e. for an exposure-endpoint. Further statistical analyses of these data are now required in order to draw conclusions on the exact level of the thresholds.
authors.affiliation: Univ Lille Nord de France, Lille, France. anne.platel@pasteur-lille.fr
authors.forename: Anne
authors.initials: A
authors.lastname: Platel
authors.forename: Fabrice
authors.initials: F
authors.lastname: Nesslany
authors.forename: Véronique
authors.initials: V
authors.lastname: Gervais
authors.forename: Nancy
authors.initials: N
authors.lastname: Claude
authors.forename: Daniel
authors.initials: D
authors.lastname: Marzin
mesh_terms: D002460:Cell Line; D020552:Comet Assay / Q000379:methods*; D004249:DNA Damage; D004305:Dose-Response Relationship, Drug; D006801:Humans; D015162:Micronucleus Tests; D009152:Mutagenicity Tests / Q000379:methods*; D009153:Mutagens / Q000633:toxicity*; D019055:No-Observed-Adverse-Effect Level; D016877:Oxidants / Q000494:pharmacology*; D013937:Thymidine Kinase / Q000235:genetics*
chemical_list: D009153:Mutagens; D016877:Oxidants; D013937:Thymidine Kinase